An irreversible inhibitor of aromatase
Related Products
Active Metabolite(s)
2798917β-hydroxy Exemestane
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Exemestane

Item No. 15008

Technical Information
Formal Name
6-methylene-androsta-1,4-diene-3,17-dione
CAS Number
107868-30-4
Synonyms
  • FCE 24304
Molecular Formula
C20H24O2
Formula Weight
Purity
≥95%
Formulation
A crystalline solid
DMF: 30 mg/mlDMSO: 30 mg/mlDMSO:PBS (pH 7.2) (1:1): 0.5 mg/mlEthanol: 20 mg/ml
λmax
246 nm
SMILES
O=C1CC[C@@]2([H])[C@]3([H])CC(C4=CC(C=C[C@]4(C)[C@@]3([H])CC[C@@]21C)=O)=C
InChi Code
InChI=1S/C20H24O2/c1-12-10-14-15-4-5-18(22)20(15,3)9-7-16(14)19(2)8-6-13(21)11-17(12)19/h6,8,11,14-16H,1,4-5,7,9-10H2,2-3H3/t14-,15-,16-,19+,20-/m0/s1
InChi Key
BFYIZQONLCFLEV-DAELLWKTSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    Exemestane is an irreversible inhibitor of aromatase (Ki = 26 nM).1 It is selective for aromatase over 5α-reductase when used at a concentration of 30 µM. Subcutaneous administration of exemestane (3-100 mg/kg per day) decreases tumor proliferation in rats with mammary tumors induced by the carcinogenic polycyclic aromatic hydrocarbon 7,12-dimethylbenz(a)anthracene (DMBA; Item No. 30383).2 Formulations containing exemestane have been used in the treatment of estrogen receptor-positive breast cancers in postmenopausal women.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Giudici, D., Ornati, G., Briatico, G., et al6-Methylenandrosta-1,4-diene-3,17-dione (FCE 24304): A new irreversible aromatase inhibitor. J. Steroid Biochem. 30(1-6), 391-394 (1988).

    2. Zaccheo, T., Giudici, D., Lombardi, P., et alA new irreversible aromatase inhibitor, 6-methylenandrosta-1,4-diene-3,17-dione (FCE 24304): Antitumor activity and endocrine effects in rats with DMBA-induced mammary tumors. Cancer Chemother. Pharmacol. 23(1), 47-50 (1989).